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he 
 
Listeria monocytogenes
 
 ActA protein mediates
 
actin-based motility by recruiting and stimulating the
 
Arp2/3 complex. In vitro, the actin monomer-binding
region of ActA is critical for stimulating Arp2/3-dependent
actin nucleation; however, this region is dispensable for
 
actin-based motility in cells. Here, we provide genetic
and biochemical evidence that vasodilator-stimulated
phosphoprotein (VASP) recruitment by ActA can bypass
defects in actin monomer-binding. Furthermore, purified
T
 
VASP enhances the actin-nucleating activity of wild-type ActA
and the Arp2/3 complex while also reducing the frequency of
 
actin branch formation. These data suggest that ActA
stimulates the Arp2/3 complex by both VASP-dependent
 
and -independent mechanisms that generate distinct popula-
 
tions of actin filaments in the comet tails of 
 
L. monocytogenes.
 
The ability of VASP to contribute to actin filament nucleation
and to regulate actin filament architecture highlights the
central role of VASP in actin-based motility.
 
Introduction
 
Listeria monocytogenes
 
 is a facultative intracellular Gram-
positive bacterium that can invade a broad range of cell types
and can cause a variety of syndromes in humans and animals.
 
Intracellular 
 
L. monocytogenes
 
 replicate in the cytoplasm
of host cells and induce the polymerization of host actin
filaments at the bacterial surface. Polarized polymerization of
actin propels the bacteria through the cytoplasm and into
pseudopod-like structures that are engulfed by neighboring
 
cells. Actin-based motility allows 
 
L. monocytogenes
 
 to spread
from cell to cell without leaving the protective intracellular
niche, and is essential for pathogenesis (Cossart and Bierne,
2001).
Actin polymerization induced by 
 
L. monocytogenes
 
 has
been intensively studied because it represents a simplified
model for understanding the regulation of actin dynamics
(Frischknecht and Way, 2001). A single bacterial surface
protein, ActA, is necessary and sufficient to induce actin-
based motility in cells and cell lysates (Domann et al., 1992;
Kocks et al., 1992, 1995; Smith et al., 1995; Cameron et al.,
1999). ActA does not directly induce polymerization of pu-
rified actin. Instead, ActA recruits and stimulates the actin-
nucleating activity of a highly conserved host protein com-
plex that contains actin-related proteins 2 and 3 and five
other subunits (Arp2/3 complex) (Machesky et al., 1994;
Welch et al., 1997, 1998). The Arp2/3 complex is required
for actin-based motility of 
 
L. monocytogenes 
 
(Yarar et al.,
1999; May et al., 1999). In the host, the Arp2/3 complex is
thought to play a critical role in cellular migration, phagocy-
tosis, and vesicle motility through interactions with proteins
of the Wiscott-Aldrich Syndrome protein (WASP)* family
(Machesky and Insall, 1998; May et al., 2000; Rozelle et al.,
2000).
 
The NH
 
2
 
-terminal domain of ActA is required for actin-
based motility (Lasa et al., 1995; Pistor et al., 1995), as it
directly binds the Arp2/3 complex and stimulates its actin-
nucleating activity (Welch et al., 1998; Skoble et al., 2000;
Zalevsky et al., 2001). Within the NH
 
2
 
-terminal domain of
ActA are three regions that contribute to actin nucleation:
an acidic stretch, an actin monomer-binding region, and a
cofilin homology sequence (Skoble et al., 2000). These three
regions have functional or sequence similarity to domains in
 
WASP family proteins
 
 
 
(Bi and Zigmond, 1999; Pistor et al.,
2000). The actin monomer-binding region in ActA, located
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between residues 60 and 101, is sufficient for monomer-
binding activity (Lasa et al., 1997, Cicchetti et al., 1999;
Skoble et al., 2000) and when this region is deleted, ActA
has no monomer-binding activity (Skoble et al., 2000). This
actin monomer-binding region is required for inducing ac-
tin nucleation in vitro, but is not essential for actin polymer-
ization or motility in cells (Skoble et al., 2000).
 
 
 
This appar-
ent paradox suggests that the actin monomer-binding region
in ActA may serve a redundant function in the context of
the host cytoplasm.
A second putative actin monomer-binding site, located be-
tween residues 121 and 138, was recently identified in NH
 
2
 
-
terminally truncated molecules of ActA lacking the first
actin-binding site (Zalevsky et al., 2001). However, these
truncations caused ActA to bind actin more tightly than full-
length protein and caused ActA to prevent both barbed and
pointed end elongation, suggesting a nonspecific interaction
with actin monomer. The fact that these truncated molecules
have different binding properties than wild-type ActA and
that deletions in the NH
 
2
 
-terminal domain of ActA can alter
the secondary structure (Cicchetti et al., 1999) suggests that
this interaction may be caused by misfolding.
The central domain of ActA does not play a direct role in
stimulating the actin-nucleating activity of purified Arp2/3
complex (Welch et al., 1998; Skoble et al., 2000; Zalevsky et al.,
2001). Although actin-based motility can occur in the absence
of the central domain, motility is greatly reduced in velocity and
efficiency (Lasa et al., 1995; Smith et al., 1996; Niebuhr et al.,
1997). The central domains of ActA from wild-type isolates
vary in that they contain either three or four proline-rich repeats
(Wiedmann et al., 1997) that recruit members of the En-
abled/vasodilator-stimulated phosphoprotein (Ena/VASP) fam-
 
ily (Chakraborty et al., 1995;
 
 
 
Pistor et al., 1995;
 
 
 
Gertler et al.,
1996; Smith et al., 1996; Niebuhr et al., 1997). Ena/VASP
family proteins are tetrameric F-actin–binding proteins that can
nucleate actin assembly in vitro but have not been demonstrated
to play a role in actin nucleation in vivo (Bachmann et al., 1999;
Huttelmaier et al., 1999; Bear et al., 2000; Bearer et al., 2000).
Ena/VASP proteins also function to recruit the actin monomer-
binding protein profilin to the bacterial surface (Reinhard et al.,
1995; Smith et al., 1996). Depletion of Ena/VASP family pro-
teins from cell-free extracts prevents 
 
L. monocytogenes
 
 motility
but not actin polymerization at the bacterial surface, whereas
profilin depletion reduces the velocity of actin-based motility
(Marchand et al., 1995; Laurent et al., 1999). Neither VASP
nor profilin is required for the reconstitution of actin-based mo-
tility with purified proteins, but both contribute independently
to increase the efficiency of motility (Loisel et al., 1999).
In this study, we tested the hypothesis that Ena/VASP re-
cruitment by the central domain of ActA functions redun-
dantly with the actin monomer-binding region of ActA to
stimulate actin polymerization. We found that VASP re-
cruitment by ActA is required to initiate actin polymeriza-
tion in the absence of actin monomer-binding activity. Fur-
thermore, we found that VASP enhances the ability of
wild-type ActA to stimulate Arp2/3 complex-mediated actin
nucleation and decreases filament branching.
 
Results
 
ActA contains a single actin monomer-binding site
 
In combination with the Arp2/3 complex, ActA is a potent
stimulator of actin nucleation. However, ActA alone seques-
ters actin monomer and causes a concentration-dependent
Figure 1. Effects of mutations in the actin 
monomer-binding region of ActA. (A) Point muta-
tions in the actin monomer-binding region prevent 
sequestration of actin monomer. The effect of the 
indicated concentrations of ActA and ActA deriva-
tives on the polymerization kinetics of 2 M actin 
was monitored using pyrene-actin polymerization 
assays. The fold inhibition was calculated by divid-
ing the maximal rate of actin polymerization by the 
maximal rate of actin polymerization in the pres-
ence of ActA and ActA derivatives. (B) Mutations 
in the actin monomer-binding region of ActA 
decrease the efficiency of Arp2/3 complex–
mediated actin nucleation. Graphs of fluorescence 
intensity (measured in arbitrary units) versus time 
in pyrene-actin polymerization assays. Fluores-
cence of pyrene-labeled actin increases when it is 
incorporated into actin polymer. Thus, an increase 
in fluorescence represents an increase in actin 
polymer mass. Initiation of polymerization of 
2 M actin was induced at time 0 in the presence 
or absence of 20 nM Arp2/3 complex and 
20 nM ActA derivatives.
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decrease in the rate of spontaneous actin polymerization (Lasa
et al., 1997; Welch et al., 1998; Skoble et al., 2000; Zalevsky
et al., 2001). An actin monomer-binding site between amino
acids 60 and 101 in ActA has been identified previously (Lasa
et al., 1997; Cicchetti et al., 1999; Skoble et al., 2000). In-
frame deletion of this region (
 

 
AB) renders ActA incapable of
inhibiting spontaneous actin polymerization (Skoble et al.,
2000). To assess the contribution of the first actin-binding
domain within the context of full-length ActA, we generated
a substitution mutation in which three lysine residues (at po-
sitions 94, 96,and 99) were changed to glutamate (ABKE)
(see Fig. 2 A). These residues were chosen because they were
shown previously to be essential for the actin-binding activity
of a peptide derived from this region (Lasa et al., 1997). We
found that the ABKE derivative of ActA was completely de-
fective at inhibiting spontaneous actin polymerization at all
concentrations tested (Fig. 1 A), confirming that this site is
the only functional actin monomer-binding site in full-length
ActA. To determine the contribution of the second putative
actin monomer-binding site, we generated an in-frame dele-
tion that removes this entire region (
 

 
AB2). We found that
this deletion had no effect on the ability of ActA to bind actin
monomer. Together, these data suggest that there is a single
actin monomer-binding site in full-length ActA, or that the
second monomer–binding site is masked in the context of an
intact NH2-terminal domain.
 
Actin monomer-binding activity is required to 
stimulate actin nucleation
 
To determine whether actin monomer-binding activity is re-
quired to stimulate Arp2/3 complex–mediated actin nucle-
ation, we tested the derivatives of ActA incapable of binding
actin monomer in the pyrene-actin polymerization assay
(Fig. 1 B). As previously described, equimolar concentra-
tions of full-length ActA and the Arp2/3 complex stimulated
actin nucleation, whereas the 
 

 
AB derivative of ActA was
dramatically reduced in its ability to activate the Arp2/3
complex (Skoble et al., 2000). The ABKE derivative was also
defective in stimulating actin nucleation, suggesting that the
actin nucleation defects observed with these derivatives are
primarily due to the defect in actin monomer-binding ac-
tivity.
 
Mutants that cannot bind actin monomer or VASP
 
Deletion of the actin monomer-binding region in ActA
greatly reduces its ability to nucleate with the Arp2/3 com-
plex in vitro; however, when this modified protein is present
at the surface of intracellular 
 
L. monocytogenes
 
, it mediates
actin polymerization and actin-based motility (Skoble et al.,
2000). This suggested that host actin-binding proteins can
function to rescue the defects associated with this mutation.
Therefore, we tested whether preventing recruitment of host
actin-binding proteins to the surface of 
 
L. monocytogenes
 
would block the rescue observed in vivo. F-actin binding
proteins of the Ena/VASP family bind to the polyproline II
helix formed by each of the proline-rich repeats in ActA
(Prehoda et al., 1999), and then recruit the actin monomer-
binding protein profilin (Reinhard et al., 1995; Smith et al.,
1996). To test whether recruitment of Ena/VASP and profi-
lin was required to rescue the actin polymerization defect of
actin monomer-binding mutations, we generated derivatives
of ActA in which all of the proline-rich repeats were mu-
Figure 2.  Mutations in the actin 
monomer-binding region and proline-
rich repeats do not alter levels of 
ActA. (A) Schematic diagram of ActA 
derivatives. Functional domains of 
ActA are labeled: (SS) signal sequence, 
(A) acidic stretch, (AB) actin monomer-
binding region, (C) cofilin homology 
sequence, (LR) long repeats, (TM) 
transmembrane domain, black boxes 
represent proline-rich repeats. (B) 
Surface-associated ActA from actA 
mutants visualized by Western blot-
ting. Surface proteins were extracted 
from an equivalent number of late log 
phase bacteria grown in Luria-Bertani 
broth. Proteins were separated on a 
7.5% polyacrylamide gel. ActA was 
detected by Western blotting using 
polyclonal anti-ActA antibodies made 
to the first 18 residues of the mature 
protein (Mourrain et al., 1997). All 
lanes shown are from a single expo-
sure of one blot. (C) Metabolic labeling 
of ActA from mutant bacteria grown 
within host cells. Strains expressing 
derivatives of ActA (containing an 
equal number of methionine residues) 
were grown in J774 macrophages. 
Host protein synthesis was inhibited 
with cyclohexamide and anisomycin and bacterial proteins were labeled with [35S] methionine. SDS-extracted proteins were resolved 
on a 7.5% gel and visualized by autoradiography. ActA and its phosphorylated forms are labeled with arrows.
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tated. As repeated sequences are difficult to mutagenize we
used a background strain containing three proline-rich re-
peats (PPP) that is fully virulent (Smith et al., 1996), and in
the remaining three repeats, all of the proline residues were
changed to glycine (GGG) (Fig. 2 A). Proline-to-glycine
substitutions have been shown to prevent VASP binding to
a peptide corresponding to this region of ActA (Niebuhr et
al., 1997), and to prevent VASP and profilin association
with 
 
L. monocytogenes 
 
expressing an 
 
actA
 
 allele with only two
glycine-rich repeats (Smith et al., 1996). We then combined
this GGG mutation with either the 
 

 
AB or the ABKE mu-
tations (
 

 
AB/GGG, ABKE/GGG), and replaced the wild-
type chromosomal 
 
actA
 
 gene in 
 
L. monocytogenes
 
 with the
mutated versions using allelic exchange. To confirm that
each of these mutated derivatives was expressed at the sur-
face of 
 
L. monocytogenes
 
 to the same extent as wild-type
ActA
 
,
 
 we performed Western analysis of proteins extracted
from the surface of equivalent numbers of bacteria using an-
tibodies that recognize the first 18 residues in mature ActA
(Fig. 2 B) (Mourrain et al., 1997). To ensure that the com-
bination of mutations did not decrease the stability of mu-
tant ActA derivatives in the cytoplasmic environment, [
 
35
 
S]
labeling of bacterial proteins from mutants grown inside
J774 macrophage-like cells was performed. By comparing
the steady state levels of ActA derivatives, we found that nei-
ther the proline-to-glycine substitution in the central do-
main nor the combination of this mutation with the charge
reversal within the actin-binding region altered the levels of
ActA at the surface of intracellular bacteria (Fig. 2 C).
To quantitatively measure the ability of 
 
L. monocytogenes
 
expressing each of these mutant derivatives of ActA to spread
from cell to cell, we performed a plaquing assay using an L2
cell monolayer. In this assay, the presence of gentamicin in
the overlay kills extracellular bacteria,
 
 
 
thus the plaque diam-
eter represents the ability of the bacteria to spread intercellu-
larly by actin-based motility over a period of 4 d. Bacteria
expressing the 
 

 
AB mutation or the ABKE mutation had
similar plaque defects (60% and 58% of wild type) (Fig. 3,
A and B). The PPP mutants, with three proline-rich repeats,
produced plaques that were equal in diameter to wild type
(100%), as reported previously (Smith et al., 1996). The
GGG mutants, expressing ActA with no functional proline-
rich repeats, made plaques that were 88% of wild type. Al-
though this plaque size is larger than the 60% reported pre-
viously for mutants expressing a deletion of this region
(Smith et al., 1996; Niebuhr et al., 1997), we believe that
this substitution mutation more accurately reflects the con-
tribution of Ena/VASP recruitment than large deletions
which would also inhibit binding of other factors including
LaXp180 (Pfeuffer et al., 2000). In contrast to the plaques
Figure 3. In the absence of actin monomer-
binding activity, intact proline-rich repeats of 
ActA are required for intercellular spread of L. 
monocytogenes. (A) Plaque assays. Images of 
plaques formed in L2 mouse fibroblast monolayers 
after 4 d of infection with the indicated L. monocy-
togenes strains. Media contains 0.7% agarose and 
10 g/ml gentamicin. Live cells are stained with 
neutral red. Bar, 10 mm. (B) Quantification of 
intercellular spread. Plaque diameters were mea-
sured for each strain and are expressed as percent 
of wild type. Error bars represent the SD between 
five and twelve independent assays.
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formed by each of the single mutations, 
 
L. monocytogenes
 
 ex-
pressing ActA molecules that were incapable of recruiting ac-
tin monomer and had mutated proline-rich repeats (
 

 
AB/
GGG and ABKE/GGG) formed pinpoint lesions that were
indistinguishable from an ActA-null mutant (
 

 
ActA). These
data demonstrate that mutations in the proline-rich repeats
act synergistically with mutations in the actin monomer-
binding region to prevent intercellular spread.
To quantify the ability of each mutant to initiate actin po-
lymerization in host cells within the first 3.5 h after infec-
tion, we infected 
 
Potoroo tridactylis
 
 kidney epithelial (PtK2)
cells because their flat morphology facilitates counting bac-
teria (Fig. 4). We found that 
 

 
99% of wild type and the
PPP mutant bacteria were associated with F-actin, and that
55 and 48%, respectively, generated actin tails. 93% of the
 

 
AB and the 90% of the ABKE mutants were associated
with actin, and 38 and 36%, respectively, formed actin tails.
Bacteria expressing ActA with the GGG mutation were 99%
associated with actin, but only 16% generated actin comet
tails. Although the majority of these GGG mutants were as-
sociated with actin clouds, in many cases the actin staining
in the clouds was faint compared with wild type, similar to
deletions of this region (Smith et al., 1996; Niebuhr et al.,
1997). In contrast, only 1% of the mutants expressing the
double mutations 
 

 
AB/GGG and ABK/GGG were associ-
ated with any cellular actin, and most grew in perinuclear
microcolonies that resembled those formed by an ActA-null
strain (
 

 
ActA). These data demonstrate that, in the absence
of actin monomer-binding activity, the proline-rich repeats
of ActA are necessary for actin nucleation in vivo.
To verify that VASP is no longer recruited to the surface
of 
 
L. monocytogenes
 
 strains expressing ActA derivatives with
the mutated proline-rich repeats, we infected HeLa cells and
 
stained for VASP with anti–human VASP antibodies. Wild-
type bacteria or mutants in the actin-binding region had in-
tense polarized VASP staining at the bacterial surface (Fig.
5). Bacteria expressing ActA with the GGG mutation did
not colocalize with VASP, nor did the double mutants,
 

 
AB/GGG and ABKE/GGG. VASP localization to the sur-
face of 
 
L. monocytogenes
 
 is independent of the presence of
F-actin, as mutations in the cofilin homology sequence pre-
vent actin polymerization but do not affect VASP localiza-
tion to the bacterial surface (Skoble et al., 2000). Together,
these data provide genetic evidence that VASP recruitment
is required to initiate actin polymerization and intercellular
spread of 
 
L. monocytogenes
 
 in the absence of the actin mono-
mer-binding activity of ActA.
 
VASP contributes to actin nucleation
 
The genetic evidence suggested that VASP recruitment was
required to initiate actin polymerization in the absence of
monomer-binding activity. Thus, we used the pyrene-actin
polymerization assay to test directly whether VASP and/or
profilin could rescue the actin-nucleating defect caused by
the deletion of the actin monomer-binding region of ActA in
vitro. In this assay, an increase in actin nucleation is best rep-
resented by an increase in the slope of the curves.
 
 
 
Indeed, the
addition of equimolar concentrations of purified recombi-
nant human VASP and 
 

 
AB together were able to stimulate
Arp2/3 complex–mediated actin nucleation with kinetics
similar to full-length ActA (Fig. 6 A). Addition of an
equimolar concentration of profilin to this reaction did not
enhance the ability of VASP to rescue the nucleation defect,
but rather slowed polymerization kinetics. Without VASP,
profilin also slowed the kinetics of actin polymerization by
the Arp2/3 complex and the 
 

 
AB derivative (unpublished
Figure 4. Ability of ActA to induce actin polymerization in vivo requires actin monomer-binding activity or intact proline-rich repeats. PtK2 
cells infected for 3.5 h with wild-type L. monocytogenes or mutants expressing the indicated derivatives of ActA. F-actin was visualized by stain-
ing with rhodamine-conjugated phalloidin and bacteria were detected by indirect immunofluorescence using polyclonal anti–L. monocytogenes 
primary antibodies followed by FITC-conjugated secondary antibodies. Bar, 10 m.
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data), a result that is consistent with profilin’s known ability
to bind and sequester actin monomer. As reported previ-
ously, VASP alone was capable of weakly nucleating actin fil-
aments (Huttelmaier et al., 1999; Bearer et al., 2000; Har-
beck et al., 2000), but the kinetics of nucleation by VASP
were not altered by the addition of the Arp2/3 complex. This
suggests that VASP is not capable of stimulating Arp2/3
complex–mediated actin nucleation in the absence of ActA.
Because VASP is a tetramer (Bachmann et al., 1999) and
full-length ActA has four proline-rich repeats, it is theoreti-
cally possible for 16 VASP molecules to associate with each
ActA molecule. To determine the amount of VASP that
stimulates ActA maximally, we added increasing concentra-
tions of VASP to equimolar concentrations of the 
 

 
AB mu-
tant and Arp2/3 complex (Fig. 6 B). We found that the abil-
ity of VASP to rescue the Arp2/3 complex–mediated actin
nucleation defect of 
 

 
AB was saturated at a 2:1 molar excess
of VASP. This suggests that ActA may function as a dimer
and that each ActA dimer binds one VASP tetramer.
Actin filaments increase the nucleation rate of stimulated
Arp2/3 complex (Machesky et al., 1999; Zalevsky et al.,
2001). Because VASP is capable of nucleating assembly of
actin filaments on its own, we tested whether the observed
rescue of the actin nucleation defect by addition of VASP to
the 
 

 
AB derivative was due to the increased initial concen-
tration of F-actin. We found that addition of a low concen-
tration of phalloidin-stabilized F-actin seeds resulted in po-
lymerization kinetics similar to VASP alone; however, unlike
VASP, the addition of the F-actin seeds did not rescue the
defect of the 
 

 
AB mutant derivative (Fig. 6 C).
The results described above clearly show that VASP can
rescue the nucleation defect of an ActA derivative that can-
not bind actin monomer. To determine whether the stimu-
latory effect of VASP requires a defective actin monomer-
binding region or is a separate stimulatory mechanism, we
directly evaluated the effect of VASP on full-length ActA.
VASP dramatically enhanced the actin-nucleating activity of
wild-type ActA, and this stimulation was more extensive
than the levels achieved by the addition of F-actin seeds (Fig.
 
6 D). This suggests that VASP may not be simply substitut-
ing for the actin monomer-binding region, but may instead
be functioning to independently stimulate nucleation.
 
VASP decreases branching of actin filaments
 
The Arp2/3 complex binds to the sides of actin filaments,
caps the pointed ends of actin filaments, and has been local-
ized to the branch points of dendritic actin arrays in vitro
and in vivo (Mullins et al., 1998; Svitkina and Borisy, 1999;
Cameron et al., 2001). Stimulation of actin nucleation
by WASP-family proteins increases the number of actin
branches formed by the Arp2/3 complex (Blanchoin et al.,
2000). To determine whether ActA stimulates the actin-
branching activity of the Arp2/3 complex, we visualized the
structures formed in vitro by staining actin filaments with
rhodamine-phalloidin. The minimal concentration at which
the nucleating activity of the Arp2/3 complex is saturated by
ActA is 10:1 (Skoble et al., 2000), thus we used this ratio to
determine whether ActA stimulated Arp2/3 complex–medi-
ated actin branch formation, and found that 56.4% of the
actin filaments generated were associated with branched
structures (Fig. 7, A and B). In contrast, actin filaments po-
lymerized in the presence of the Arp2/3 complex alone or
the Arp2/3 complex and the 
 

 
AB derivative were infre-
quently branched (2.0% and 3.6%, respectively). This dem-
onstrates that ActA stimulates the branching activity of the
Arp2/3 complex and that the actin monomer-binding re-
gion of ActA is required for this function.
Next, we wanted to evaluate whether VASP had any effect on
actin filament architecture. The vast majority of actin filaments
that were nucleated in the presence of VASP and the Arp2/3
complex were unbranched (2.6%) (Fig. 7, A and B). In the
VASP-containing reactions there were occasional filaments that
appeared thicker and many-fold brighter (unpublished data),
suggesting that VASP may bundle actin filaments into parallel
arrays. Because VASP was able to rescue the defect in nucle-
ation of the 
 

 
AB derivative, we wanted to test whether VASP
could also rescue the branching defect of this mutant. However,
actin filaments nucleated in the presence of the Arp2/3 com-
Figure 5. VASP recruitment is impaired 
in mutants expressing ActA with 
mutated proline-rich repeats. HeLa 
Cells were infected for 3.5 h with wild-
type or indicated mutant strains. After 
fixation, VASP was detected with 
affinity-purified polyclonal anti–human 
VASP antibodies, followed by 
rhodamine-conjugated secondary anti-
bodies. L. monocytogenes were detected 
by staining with FITC-conjugated poly-
clonal anti–L. monocytogenes antibodies. 
Bar, 10 m.
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plex, VASP, and the 
 

 
AB derivative were only 3.2% branched.
This demonstrates that although VASP can rescue the actin nu-
cleation defect of the 
 

 
AB derivative, the actin filaments pro-
duced have a dramatically different organization than those
nucleated by wild-type ActA and the Arp2/3 complex. Further-
more, VASP also reduced branching by full-length ActA and
the Arp2/3 complex by greater than fourfold, to 12.8%.
These observations suggest that actin filaments nucleated
directly by ActA and the Arp2/3 complex form branched ar-
rays, but that those nucleated in the presence of VASP form
primarily unbranched structures that can be bundled into
parallel arrays. The NH
 
2
 
-terminal domain of ActA (A263),
which has been shown to be fully capable of stimulating
Arp2/3 complex–mediated actin nucleation (Welch et al.,
1998; Skoble et al., 2000), also stimulated Arp2/3-depen-
dent actin branching to 47.0% (Fig. 7, A and B). Despite
the fact that this derivative lacks the proline-rich repeats of
ActA, addition of VASP to this reaction also decreased actin
branching, but less than twofold, to 28.7%. These data sug-
gest that in vitro, the ability of VASP to inhibit actin
branching is only partially dependent on the ability to be re-
cruited by ActA.
 
Discussion
 
L. monocytogenes
 
 exploits a highly conserved mechanism of
actin-based motility and provides a unique tool for dissec-
tion of the host factors involved in this process. The interac-
tion of ActA with the Arp2/3 complex, VASP, and mono-
meric actin suggests that it recruits each of these proteins to
play a critical role in motility. The results of this study pro-
vide both genetic and biochemical evidence that VASP re-
cruitment to the surface of 
 
L. monocytogenes
 
 by the proline-
rich repeats of ActA functions to stimulate actin nucleation.
This finding was unexpected because the central domain of
ActA was found to play no role in directly stimulating the
Figure 6. Purified VASP rescues the 
actin nucleation defect of an ActA 
derivative deficient for actin monomer 
binding. (A) Pyrene-actin polymerization 
assays carried out in the presence of 
VASP and profilin. Kinetics of 2 M 
actin polymerization was monitored in 
the presence or absence of 100 nM 
ActA, AB derivative, VASP, or profilin 
and in the presence or absence of 20 nM 
Arp2/3 complex as indicated. The fold 
increase in polymerization rate was 
determined by calculating the maximal 
rate of polymerization and dividing that 
value by the rate of spontaneous actin 
polymerization and is presented in
parentheses. (B) VASP rescue of actin 
nucleation defect saturates at a ratio of 
2:1 with AB. Pyrene-actin polymeriza-
tion assays were carried out with 2 M 
actin and 20 nM Arp2/3 complex, with 
either 20 nM ActA or AB in the pres-
ence of the indicated concentration of 
VASP. The fold increase in polymeriza-
tion rate is presented in parentheses. 
(C) Actin filaments do not rescue the 
actin nucleation defect of the AB deriv-
ative. Pyrene-actin polymerization 
assays were carried out with 2 M actin 
in the presence or absence of 20 nM 
Arp2/3 complex, ActA or AB, 40 nM 
VASP, or 200 nM phalloidin-stabilized 
F-actin seeds, as indicated. The fold 
increase in polymerization rate is 
presented in parentheses. (D) VASP stim-
ulates actin nucleation by ActA and the 
Arp2/3 complex Pyrene-actin polymer-
ization assays were carried out with 2 
M actin in the presence or absence of 
20 nM Arp2/3 complex, ActA or AB, 
40 nM VASP, or 200 nM phalloidin-
stabilized F-actin seeds, as indicated. 
The fold increase in polymerization rate 
is presented in parentheses.
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Arp2/3 complex (Skoble et al., 2000; Zalevsky et al., 2001).
In fact, numerous studies have demonstrated that the central
domain of ActA is not sufficient to induce actin polymeriza-
tion in host cell cytoplasm (Friederich et al., 1995; Lasa et
al., 1995, 1997; Pistor et al., 1995, 2000; Smith et al., 1996;
Niebuhr et al., 1997; Bear et al., 2000; Skoble et al., 2000),
although a recent report has demonstrated that filamentous
actin can be recruited to the surface of beads coated with
only this domain of ActA (Fradelizi et al., 2001). Previously,
it had been proposed that this region functions to enhance
the efficiency of motility by delivering profilin/actin com-
plexes to elongating filaments (Theriot et al., 1994), or by
recruiting Ena/VASP to anchor elongating filaments at the
bacterial surface (Laurent et al., 1999). However, we find
that in the absence of actin monomer-binding activity, the
proline-rich repeats of ActA are required for the initiation of
actin polymerization at the bacterial surface. In vitro, we
find that addition of purified recombinant VASP rescues the
actin nucleation defect of an ActA mutant that cannot bind
actin monomer, and that profilin is not required for this res-
cue. These data suggest that VASP recruitment directly facil-
itates actin nucleation, and are consistent with the finding
that VASP and profilin can independently increase the effi-
ciency of actin-based motility (Loisel et al., 1999). Our find-
ings bring to light the interplay between the central domain
and the NH2-terminal domain of ActA in actin nucleation;
however, our observations do not exclude the possibility that
profilin recruitment may further enhance motility.
ActA and WASP family proteins both require actin mono-
mer-binding regions to directly stimulate actin nucleation
with Arp2/3 complex (Machesky et al., 1999; Skoble et al.,
2000). Thus, the observation that VASP, an F-actin binding
protein, can rescue the actin nucleation defect caused by an
actin monomer-binding region mutation was initially sur-
prising. However, we also find that VASP stimulates actin
nucleation by full-length ActA, suggesting that VASP is not
merely substituting as a replacement for the actin-binding
region, but rather that VASP stimulates nucleation by a dis-
tinct mechanism, perhaps by delivering actin filaments to
the Arp2/3 complex. In support of this hypothesis, a num-
ber of F-actin binding proteins have recently been described
that stimulate the nucleating activity of the Arp2/3 complex,
Figure 7. VASP recruitment decreases 
actin branch formation by ActA and the 
Arp2/3 complex. (A) Images of actin fila-
ment structures nucleated in the pres-
ence or absence of VASP. 4 M actin 
was polymerized in the presence of 20 
nM Arp2/3 complex (top) or 20 nM 
Arp2/3 complex and 200 nM VASP 
(bottom) with no ActA (a and e), 200 nM 
ActA (b and f) , 200 nM AB (c and g), 
and 200 nM A263 (d and h). Actin 
structures were stabilized and labeled 
with addition of 4 M rhodamine-
phalloidin and visualized by direct 
microscopic observation. (B) Quantifica-
tion of actin branches formed in 
presence of VASP. The values are 
presented as a percent of the total popu-
lation of actin filaments that appear in 
branched structures. All of the filaments 
in a given field were counted; when two 
or more actin filaments were found to 
intersect, each was scored as branched. 
The data represent a minimum of 800 
filaments for each condition from two to 
five independent experiments.
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including cortactin, Myo1p, and Abp1p (Lee et al., 2000;
Goode et al., 2001; Uruno et al., 2001; Weaver et al., 2001).
The mechanism by which F-actin binding proteins stimulate
the nucleating activity of the Arp2/3 complex is not well un-
derstood. It is possible that this class of nucleating proteins
function by presenting actin filaments to the Arp2/3 com-
plex, which stimulates dendritic nucleation. In the case of
cortactin, stimulation of nucleation leads to increased actin
branching (Weaver et al., 2001); however, we find that
VASP decreases branching. Thus, whereas these F-actin
binding proteins may stimulate nucleation via a similar
mechanism, they appear to give rise to different filament
structures, suggesting that Arp2/3-dependent actin branch-
ing may be separable from nucleation.
The different architecture of the actin filaments we ob-
served in the presence or absence of VASP is reminiscent of
the divergent structures observed in L. monocytogenes tails.
These comet tails are composed of distinct populations of
actin filaments: an outer cortex of long parallel actin fila-
ments and a core containing shorter more orthogonal actin
structures (Zhukarev et al., 1995; Sechi et al., 1997). The
similarity of the filament populations observed in vitro with
those formed in vivo, suggest that VASP may be responsible
for organizing actin filaments into the parallel structures
found at the cortex of comet tails, whereas the orthogonal
filament architecture at the core may be organized by the
branching properties of ActA and the Arp2/3 complex. Al-
though VASP is most concentrated at the older bacterial
pole, it is also localized throughout the longitudinal surface
of intracellular L. monocytogenes. Thus, actin filaments paral-
lel to the longitudinal axis of motile bacteria would encoun-
ter more VASP molecules than those extending from the
rear of bacteria. Highlighting the structural role of VASP in
actin-based motility, depletion of VASP from cell lysates
prevents actin-based motility of L. monocytogenes but does
not prevent actin cloud formation (Laurent et al., 1999),
and mutants that cannot recruit VASP have defects in
cloud-to-tail transition and in initiating motility (Smith et
al., 1996; Niebuhr et al., 1997). Thus, VASP localization to
the bacterial surface may play a critical role in enhancing ac-
tin nucleation and in generating an actin filament architec-
ture that is optimal for motility. Consistent with this hy-
pothesis, mutant L. monocytogenes that cannot form aligned
longitudinal actin arrays are not motile (Kuhn et al., 1990;
Zhukarev et al., 1995), and a mutant that cannot bind
VASP polymerizes actin filaments that are threefold less
aligned than wild type (Smith et al., 1996). Thus, it is possi-
ble that although actin polymerizes at the surface of these
bacteria, without VASP the filaments are less capable of
forming a structure that is productive for actin-based mo-
tility.
L. monocytogenes is studied as a simplified model system
for the investigation of actin-based motility of host cells;
however, cellular migration is significantly more complex
than bacterial motility in that it requires precise directional
coordination of protrusive forces. Although Ena/VASP pro-
teins clearly enhance L. monocytogenes motility, these pro-
teins have been recently found to have a negative regulatory
effect on cellular migration (Bear et al., 2000). Our data
provide at least two possible mechanisms for the enigmatic
role of VASP in cellular migration. Overexpression of VASP
could inhibit cellular migration by artificially stimulating
actin nucleation at unproductive sites. Conversely, when
VASP is sequestered this may increase the polarization of
protrusion sites by increasing the threshold of actin nucleat-
ing factors required for lamellipodia formation. Alterna-
tively, changing the local concentration of Ena/VASP may
alter the architecture of actin filaments, making them more
or less productive for motility. In support of this latter hy-
pothesis, recent ultrastructural analyses of actin filament ar-
chitecture in lamellipodia of cells absent of Ena/VASP fam-
ily proteins demonstrates that these cells appear to have
more highly branched actin structures. Furthermore, overex-
pression of Ena/VASP results in lamellipodia in which actin
filaments appear to have fewer branches and are more paral-
lel (F. Gertler, personal communication). Ultrastructural
analyses of L. monocytogenes comet tails in these cells may
provide further insight into the role of Ena/VASP family
proteins in actin-based motility.
Materials and methods
Expression and purification of 6 His-tagged derivatives of ActA
L. monocytogenes strains secreting 6 His-tagged full-length ActA, the
A263 derivative, and the AB derivative (deleted of amino acids 60–101)
were described previously (Table I). The deletion of residues 102–135
(AB2) that remove the second putative actin-binding site was accom-
plished by splice- by-overlap extension (SOE) PCR (Horton et al., 1990)
using primer 5-GCAAAAGCAGAGAAAGGTCCGGGTCTGTCATCGGAT-
AGCGCA-3 and its reverse compliment as described in Skoble et al.
(2000). The ABKE substitution (in which codons for lysine residues 94, 96,
and 99 were changed to codons for glutamate) was generated using the
Quickchange mutagenesis kit (Stratagene) according to manufacturer rec-
ommendations. pDP-3934 (Skoble et al., 2000) was used as template
and primers 5-GCAGACCTAATAGCAATGTTGGAAGCAGAAGCAGAG-
GAAGGTCCGAATAACAATAATAAC-3 and its reverse complement were
used to generate p-ABKE (pDP-4230). An HpaI/KpnI restriction fragment
surrounding this mutation was cloned into pDP-2717 (Welch et al., 1998)
which contains the full-length His-tagged ActA and the DNA sequence of
the resulting plasmid pABKEHis (pDP-4231) was confirmed. This plasmid
was transformed into the overexpression strain of L. monocytogenes DP-
L3935 and 6 His-tagged proteins were purified from L. monocytogenes
culture supernatants as described previously (Skoble et al., 2000).
Generation of isogenic ActA mutants
Isogenic 10403S-derived mutants expressing the ActA, AB, and the
PPP alleles were described previously (Table I). To replace the wild-type
chromosomal copy of actA with the ABKE mutation, the temperature-
sensitive plasmid pABKE (pDP-4230, above) was used. To generate the
GGG mutation (from which residues 299–333 were deleted and proline
residues 266, 267, 268, 269, 336, 337, 338, 339, 381, 382, and 384
were changed to glycine), a plasmid encoding the GGG actA allele was
constructed by performing three consecutive rounds of SOE PCR (Hor-
ton et al., 1990). For the first round of PCR, pDP2118, which contains
a deletion of proline-rich repeat 2 corresponding to the deletion in
PPP, was used as the template (Smith et al., 1996). Primers 5-CTCT-
TCTTCTGTTCCGATTCCTCCGAAATCAGAGAAATTTTC-3 and its re-
verse compliment were used to mutagenize proline-rich repeat 3. This
mutated fragment was gel purified, and then used as the template for the
next round of SOE PCR to mutate proline-rich repeat 1 as described pre-
viously (Smith et al., 1996). The resultant fragment was purified and
used as template for mutagenesis of proline-rich repeat 4 as described
previously (Smith et al., 1996). The final PCR product was digested us-
ing SalI and KpnI and ligated into similarly digested pDP-3934 to gener-
ate pGGG (pDP-4035). Plasmids encoding the mutation AB/GGG
(pDP-4234) and ABKE/GGG (pDP-4238) were generated by sublcloning
SphI/KpnI fragments from pAB (pDP-3993) and pABKE (pDP-2430)
into pGGG (pDP-4035). To replace the chromosomal copy of actA with
the mutated alleles, allelic exchange was performed as described by
Skoble et al. (2000). To verify that each strain contained the desired de-
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letion, chromosomal DNA was amplified by PCR and the region flank-
ing each deletion was sequenced.
Analysis of ActA expression
To confirm that the desired allele of actA was expressed on the surface of
L. monocytogenes, bacteria were grown to an OD600 of 0.5, and then
washed once with PBS containing 10 mM EDTA. Surface proteins were
extracted from samples corresponding to equivalent bacterial numbers
(calculated by OD600) as described previously (Mourrain et al., 1997;
Skoble et al., 2000). Extracted proteins were separated on a 7.5% SDS-
PAGE gel and transferred to a nitrocellulose membrane (Bio-Rad Labora-
tories). ActA was detected by immunoblotting using affinity-purified rab-
bit polyclonal antibodies (A18K) raised against a peptide derived from the
first 18 residues of mature ActA (Mourrain et al., 1997) , provided by Pas-
cale Cossart (Institut Pasteur, Paris, France), followed by detection with
ECL-plus detection system as described by the manufacturer (Amersham
Pharmacia Biotech).
[35S] methionine–labeling of bacterial surface proteins from L. monocy-
togenes strains grown within J774 macrophage-like cells was performed as
described (Brundage et al., 1993).
Analysis of L. monocytogenesinfected tissue culture cells
HeLa and PtK2 cells were grown on glass coverslips in RPMI 1640 me-
dium (Life Technologies) supplemented with 10% FBS, 2 mM glutamine
and, 1 mM pyruvate. Subconfluent monolayers were infected with L.
monocytogenes as described (Smith et al., 1996). For VASP staining, HeLa
cells were fixed with 3.2% paraformaldehyde at 3.5 h after infection. VASP
was detected with affinity-purified rabbit polyclonal anti–human VASP pri-
mary antibodies (Smith et al., 1996), followed by rhodamine-conjugated
goat anti–rabbit secondary antibodies (Jackson ImmunoResearch Laborato-
ries). L. monocytogenes were stained directly with fluorescein-conjugated
anti–L. monocytogenes antibodies (DIFCO Laboratories). For quantifica-
tion of bacteria associated with F-actin, infected PtK2 Cells were fixed as
above and stained with rhodamine-phalloidin and rabbit polyclonal anti-
Listeria antibodies (DIFCO Laboratories) followed by FITC-conjugated don-
key anti–rabbit secondary antibodies. Infected cells were visualized using
a TE300 inverted microscope (Nikon). Images were captured with a CCD
camera (Hammamatsu) and pseudocolored and merged using Metamorph
software (Universal Imaging).
Plaque assays were performed in monolayers of L2 fibroblast cells as
described previously (Jones and Portnoy, 1994). Plaque size was deter-
mined by capturing images using a digital camera and measuring the di-
ameter of at least 15 plaques per experiment using Canvas software
(Deneba). Mutant plaque size was compared with wild type for each ex-
periment and the mean percent plaque size was averaged from between
five and twelve independent experiments.
Purification of human VASP and profilin
Human VASP was expressed in Spodoptera frugiperda Sf9 cells using the
Bac-to-Bac baculovirus expression system (Invitrogen). To generate an
appropriate baculovirus strain, the VASP cDNA (EST clone ID 844271;
Incyte Genomics) was amplified by PCR using the following primers: 5-
CGAGGATCCATGAGCGAGACGGTCATCTG-3, and 5-CGAGGTAC-
CTCAGGGAGAACCCCGCTTCCTCAG-3. The PCR product was di-
gested with BamHI and KpnI and subcloned into the corresponding sites
in the pFastBacHTb vector (Invitrogen). A baculovirus strain was pre-
pared from this expression vector according to procedures supplied with
the Bac-to-Bac system.
For VASP expression, Sf9 cells were infected for 72 h at 27C with the
baculovirus strain expressing VASP. Infected cells were pelleted by centrifu-
gation at 250 g for 10 min, washed once with PBS, and pelleted again. Pel-
lets were quick frozen in liquid N2, and cells were lysed by thawing in an
equal volume 50 mM KPO4, 300 mM KCl, and LPC (10 g/ml leupeptin,
pepstatin A, and chymostatin from Chemicon International). The cellular
debris was pelleted at 250,000 g and the extract was supplemented with 20
mM imidazole. 1 ml of NiNTA agarose, equilibrated in wash buffer (50 mM
KPO4, 300 mM KCl, and 20 nM imidazole), was incubated with the extract
for 1 h at 4C. The beads were pelleted by centrifugation at 200 g, washed
three times with wash buffer, and then transferred to a 2-ml capacity quick
spin column. The beads were washed with three-column volumes of wash
buffer supplemented with a final concentration of 1 M KCl, and three times
in wash buffer by gravity flow. Excess buffer was removed by centrifugation
at 200 g for 1 min. Bound proteins were eluted by the addition of 1 M imi-
dazole. VASP was further purified by gel filtration chromatography over a
Superdex 200 column (Pharmacia) equilibrated in control buffer (20 mM
MOPS pH 7.0, 100 mM KCl, 2 mM MgCl2, 5 mM EGTA, 1 mM EDTA, 0.2
mM ATP, 0.5 mM DTT, 10% vol/vol glycerol). VASP was then concentrated
using a 30-kD centrifugal filtration device (Millipore). Profilin was purified
from human platelets as described previously (Janmey, 1991).
Pyrene-actin polymerization assays
Pyrene-actin polymerization assays were performed as described previ-
ously (Skoble et al., 2000) with the following modifications. Pyrene-actin
and unlabeled actin were mixed in G-buffer (2 mM Tris pH 7.6, 0.2 mM
CaCl2, 0.2 mM ATP, 0.2 mM DTT) to generate a 6-M monomeric actin
solution with 10% pyrene-actin. 6 l of control buffer (20 mM MOPS,
pH7.0, 100 mM KCl, 2 mM MgCl2, 5 mM EGTA, 1 mM EDTA, 0.2 mM
ATP, 0.5 mM DTT 10% v/v glycerol) or Arp2/3 complex, VASP, or Profilin
in control buffer, was mixed with 6 l 10  initiation buffer (20 mM
MgCl2, 10 mM EGTA, 5 mM ATP) and 28 l G-buffer or up to 28 l ActA
in G-buffer. This 40 l solution was mixed with 20 l of monomeric actin
solution to initiate polymerization. Assembly kinetics were monitored us-
ing a Fluorolog 3 fluorometer (excitation wavelength 365 nm, emission
wavelength 407 nm; Instruments S.A.) maintained at a temperature of
25C. The maximal rate of polymerization was determined by calculating
the linear regression of the maximal slope using Kaleidagraph software
(Synergy Software). Fold inhibition of polymerization by ActA was calcu-
lated by dividing the maximal rate of polymerization in the absence of
ActA by the maximal rate in the presence of ActA.
Branching assay
The branching assay was carried out essentially as described in by Blan-
choin et al. (2000) and Amann and Pollard (2001). All proteins except actin
monomer were mixed at room temperature in 1 KMEI (50 mM KCl, 1 mM
MgCl2, 1 mM EGTA, 10 mM imidazole pH 7.0) with 0.2 mM ATP and 1 mM
DTT. Actin monomer in G-buffer (5 mM Tris pH 7.4, 0.2 mM CaCl2, 0.2
mM DTT, 0.2 mM ATP) was added to a final concentration of 4 M. After
polymerization proceeded for 1 min, rhodamine-phalloidin was added to a
final concentration of 4 M. Polymerization was allowed to proceed at room
temperature for 5 min after the addition of rhodamine-phalloidin. Samples
were diluted 625-fold into fresh fluorescence buffer (50 mM KCl, 1 mM
MgCl2, 100 mM DTT, 10 mM imidazole, pH 7.0, 0.5% methylcellulose, 20
g/ml catalase, 100 g/ml glucose oxidase, 3 mg/ml glucose) and 1.3 l di-
luted samples were applied to coverslips precoated with 0.1% nitrocellulose
in amyl acetate. Branches were visualized by fluorescence microscopy and
images were analyzed using Metamorph software (Universal Imaging).
Table I. L. monocytogenes strains used in this study
actA allele
Strain number: 
surface-associated ActA
Strain number: 
secreted 6 His-tagged ActA Reference
WT 10403S DP-L2723
Bishop and Hinrichs, 1987;
Welch et al., 1998
ActA DP-L3078 – Skoble et al., 2000
AB DP-L3944 DP-L3987 Skoble et al., 2000
ABKE DP-L4232 DP-L4233 This study
AB2 – DP-L4226 This study
PPP DP-L2157 – Smith et al., 1996
GGG DP-L4032 – This study
AB/GGG DP-L4236 – This study
ABKE/GGG DP-L4248 – This study
A263 – DP-L4007 Welch et al., 1998
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